Smith Darren Charlton bought TLX
September 7, 2026 · Form 4 insider transaction
Smith Darren Charlton bought 2,071 shares of Telix Pharmaceuticals Limited at $9.66 per share, a transaction worth $20.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 7 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,071
Price
$9.66
Total value
$20.0K
InsiderSmith Darren Charlton
Role—
SecurityOrdinary Shares
Transaction codeP: Open-market purchase
Transaction dateSeptember 7, 2026
Filing dateSeptember 14, 2026
Shares owned after13,992
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares purchased by the Reporting Person under the Employee Share Purchase Plan section of the Issuer's Equity Incentive Plan ("AU ESPP"), which shares were allocated on September 7, 2026, based on the Reporting Person's contributions to the AU ESPP from January 1, 2026 - June 30, 2026.; Purchase price is recorded in Australian Dollars.